Abstract

Dendroaspis natriuretic peptide (DNP), a new member of the natriuretic peptide family, is structurally similar to atrial, brain, and C-type natriuretic peptides. However, the effects of DNP on the cardiac function are poorly defined. In the present study, we examined the effect of DNP on the cardiac L-type Ca2+ channels in rabbit ventricular myocytes. DNP inhibited the L-type Ca2+ current (ICa,L) in a concentration dependent manner with a IC50 of 25.5 nM, which was blocked by an inhibitor of protein kinase G (PKG), KT5823 (1 µM). DNP did not affect the voltage dependence of activation and inactivation of ICa,L. The α1c subunit of cardiac L-type Ca2+ channel proteins was phosphorylated by the treatment of DNP (1 µM), which was completely blocked by KT5823 (1 µM). Finally, DNP also caused the shortening of action potential duration in rabbit ventricular tissue by 22.3 ± 4.2% of the control (n = 6), which was completely blocked by KT5823 (1 µM). These results clearly indicate that DNP inhibits the L-type Ca2+ channel activity by phosphorylating the Ca2+ channel protein via PKG activation.

Highlights

  • A new member of the natriuretic peptide family, dendroaspis natriuretic peptide (DNP), has been reported

  • The actions of DNP on ICa,L were examined in adult rabbit ventricular myocytes

  • We have examined the effects of DNP on the cardiac L-type Ca2+ channels, and clarified its action mechanism at molecular level

Read more

Summary

Introduction

A new member of the natriuretic peptide family, dendroaspis natriuretic peptide (DNP), has been reported. DNP, originally isolated from the venom of the Dendroaspis angusticeps or green Mamba snake, is a peptide of 38 amino acids containing a 17 amino acid disulfide ring structure with a 15-residue C terminal extension (Schweitz et al, 1992). This peptide shares structural similarity to atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) of myocardial cell origin, and C-type natriuretic peptide (CNP) of endothelial cell origin (Schweitz et al, 1992). Synthetic DNP suggests its potential use in the cardiovascular disease states such as CHF, the effects of DNP on the cardiac function are poorly defined

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call